about
Thioridazine induces major changes in global gene expression and cell wall composition in methicillin-resistant Staphylococcus aureus USA300Old drugs--new usesIntegrating Clinical Phenotype and Gene Expression Data to Prioritize Novel Drug UsesDiscovery of very late antigen-4 (VLA-4, alpha4beta1 integrin) allosteric antagonists.Characterization of genes encoding for acquired bacitracin resistance in Clostridium perfringensNonracemic Antifolates Stereoselectively Recruit Alternate Cofactors and Overcome Resistance in S. aureus.Antitubercular pharmacodynamics of phenothiazinesThioridazine pharmacokinetic-pharmacodynamic parameters "Wobble" during treatment of tuberculosis: a theoretical basis for shorter-duration curative monotherapy with congeners.Molecular tools for rapid identification and novel effective therapy against MDRTB/XDRTB infections.Phenothiazines as anti-tubercular agents: mechanistic insights and clinical implications.Molecular dynamics simulations of the interactions of medicinal plant extracts and drugs with lipid bilayer membranes.Thioridazine inhibits gene expression control of the cell wall signaling pathway (CWI) in the human pathogenic fungus Paracoccidioides brasiliensis.Nitrate enhances the survival of Mycobacterium tuberculosis during inhibition of respiration.Reversal of methicillin resistance in Staphylococcus aureus by thioridazine.Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity.Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.Molecular mechanisms of thioridazine resistance in Staphylococcus aureusSynthesis and synergistic antimycobacterial screening of chlorpromazine and its metabolites
P2860
Q21133515-A4995745-1ED0-4435-AFBD-1C53CC842588Q24650207-F0885B9B-B9D2-423C-91B5-910E069BD9F3Q31143112-91FEDD90-BC31-424A-A753-FD14DB54B500Q33763221-6F188AC6-7579-4E97-B677-358569386959Q34412427-8D772E93-30D8-478D-AF00-9AF7B2F84875Q36522836-BB5B0C9C-8E43-4523-B4F3-4DEAFD98DB31Q36675149-C0DE3CE8-1130-4FF2-9D6C-4976E8C7A212Q37335803-A947437F-F30A-457E-B2C0-4A19A4AFBD44Q37727181-1A01F1B4-3E66-454F-8B66-75655CCC7344Q37947678-5AC8146B-6266-48CE-ABBC-30553E5219F9Q38099377-F8F20716-366D-4EC7-BB48-ACB8E18961E8Q40763094-EF811814-8D34-463D-B03C-9CDB4E97A076Q43112687-503A2AD3-9EC5-465D-9A51-263EEE426C50Q46331077-D9D1FA39-67B7-42C9-81DC-7C8950C2DDCBQ48315975-22B25132-8EB1-4B15-9F98-37E559E01186Q50780166-617C5C9C-F73C-4B26-A294-7EFFAAA07D6EQ58796132-5A967F0F-F292-4335-BFC4-DEBCE291FECFQ58866930-F8A46610-F2AB-4233-BBB3-382478291B45
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Thioridazine: resurrection as an antimicrobial agent?
@ast
Thioridazine: resurrection as an antimicrobial agent?
@en
Thioridazine: resurrection as an antimicrobial agent?
@nl
type
label
Thioridazine: resurrection as an antimicrobial agent?
@ast
Thioridazine: resurrection as an antimicrobial agent?
@en
Thioridazine: resurrection as an antimicrobial agent?
@nl
prefLabel
Thioridazine: resurrection as an antimicrobial agent?
@ast
Thioridazine: resurrection as an antimicrobial agent?
@en
Thioridazine: resurrection as an antimicrobial agent?
@nl
P2860
P1476
Thioridazine: resurrection as an antimicrobial agent?
@en
P2093
H K R Thanacoody
P2860
P304
P356
10.1111/J.1365-2125.2007.03021.X
P407
P577
2007-11-01T00:00:00Z